A Multicenter, Open-Label, Single-Arm, Phase 2 Study to Evaluate the Efficacy and Safety of Hetrombopag in Patients with Severe Aplastic Anemia (SAA)

被引：6
|
作者：
Zhang, Fengkui
Peng, Guangxin
He, Guangsheng
Chang, Hong
Gao, Sujun
Liu, Xinjian
Chen, Tong
Li, Pei
Han, Bing
Miao, Miao
Ge, Zheng
Ge, Xiaoyan
Li, Fei
Li, Yingmei
Wang, Shunqing
Wang, Yi
Shen, Yaqi
Tai, Yanfei
Zhang, Tao
Zhu, Bo
Zou, Jianjun
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-137319
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A Multicenter, Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Saroglitazar in Patients With Primary Biliary Cholangitis
    Vuppalanchi, Raj
    Gonzalez-Huezo, Ma Sarai
    Payan-Olivas, Ramon
    Munoz-Espinosa, Linda E.
    Shaikh, Farheen
    Cruz-Lopez, Jose L. Pio
    Parmar, Deven
    [J]. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (04) : E00327
  • [2] Safety and efficacy of hetrombopag in patients with chronic immune thrombocytopenia: a single-arm, open-label, multi-center phase 1 study
    Mei, Heng
    Chen, Xiequn
    Zhou, Jianfeng
    Luo, Jianmin
    Shi, Qingzhi
    Liu, Jing
    Wu, Depei
    Chen, Guoan
    Tai, Yanfei
    Xiong, Junye
    Zou, Jianjun
    Hu, Yu
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (02)
  • [3] A multicenter phase II study on the efficacy and safety of hetrombopag in patients with severe aplastic anemia refractory to immunosuppressive therapy
    Peng, Guangxin
    He, Guangsheng
    Chang, Hong
    Gao, Sujun
    Liu, Xinjian
    Chen, Tong
    Li, Pei
    Han, Bing
    Miao, Miao
    Ge, Zheng
    Ge, Xiaoyan
    Li, Fei
    Li, Yingmei
    Wang, Shunqing
    Wang, Yi
    Shen, Yaqi
    Zhang, Tao
    Zou, Jianjun
    Zhang, Fengkui
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [4] Subcutaneous CERA for the Maintenance Treatment of Anemia in Pediatric Patients With CKD: A Phase 2, Open-Label, Single-Arm, Multicenter Study
    Warady, Bradley A.
    Reigner, Sylvie Meyer
    Tirodkar, Chitra
    Drozdz, Dorota
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (06) : 684 - +
  • [5] Efficacy and safety of tunlametinib in patients with advanced NRAS-mutant melanoma: A multicenter, open-label, single-arm, phase 2 study.
    Si, Lu
    Zou, Zhengyun
    Zhang, Weizhen
    Fang, Meiyu
    Zhang, Xiaoshi
    Luo, Zhiguo
    Chen, Jing
    Huang, Gang
    Zhang, Peng
    Cheng, Ying
    Liu, Jiwei
    Liu, Jiyan
    Zhang, Junping
    Wu, Di
    Chen, Yu
    Ma, Xiaobiao
    Wei, Xiaoting
    Sun, Peng
    Jia, Zhongwei
    Guo, Jun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] A multicenter, open-label, single-arm phase 1/2 study to evaluate the safety and efficacy of FCN-159 in pediatric participants with neurofibromatosis type 1
    Hu, Xiaojie
    Wang, Jinhu
    Li, Wenbin
    Zeng, Kang
    Li, Yanling
    Tao, Juan
    Guan, Zhonghai
    Kang, Zhuang
    Xu, Zhongyuan
    Li, Changxing
    Ma, Yaohui
    Yang, Liu
    Wu, Zhuli
    Han, Pu
    Lin, Hongmei
    Li, Ben
    Hui, Ai-Min
    Wang, Xingli
    Lin, Xiaoxi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open-label, single-arm, phase 3, and postmarketing clinical study
    Onodera, Masafumi
    Uchiyama, Toru
    Ariga, Tadashi
    Yamada, Masafumi
    Miyamura, Takako
    Arizono, Hironori
    Morio, Tomohiro
    [J]. IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (07)
  • [8] Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open-label, single-arm phase II study
    Srimuninnimit, Vichien
    Sriuranpong, Virote
    Suwanvecho, Suthida
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (03) : 255 - 260
  • [9] Safety and Efficacy of Iguratimod in Patients with Active Rheumatoid Arthritis: A Multicenter, Single-Arm, Open-Label, Real World Study
    Mu, Rong
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [10] Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
    Shuichi Ito
    Yuya Nishiyama
    Kenkichi Sugiura
    Kazuaki Enya
    [J]. Clinical and Experimental Nephrology, 2022, 26 : 350 - 358
12345